Ancient Protein Helps E. coli Thwart Viral Attack

When engineered to use a four-billion-year-old version of the protein thioredoxin, the bacteria can stall bacteriophage replication, a new study shows.

Written byAshley Yeager
| 3 min read

Register for free to listen to this article
Listen with Speechify
0:00
3:00
Share

CDCResurrecting ancient proteins in modern E. coli can protect the bacterium from viral infection, scientists reported today (May 9) in Cell Reports. Researchers from Spain engineered the genetic sequences that code for ancestral forms of the protein thioredoxin—including one that would have existed about 4 billion years ago—and found that not only did the old protein function in the cells, but when these bacteria were exposed to the bacteriophage T7, they fended off viral infection.

“This is an interesting strategy that impedes the propagation of the virus,” biochemist Reinhard Sterner of the University of Regensburg in Germany told The Scientist. “It could be a new mode of viral resistance, which is pretty cool.”

The project got its start from an interest in plants. Specifically, Asunción Delgado and colleagues at the University of Granada knew that proteins in plants that aid viral replication haven’t evolved so much so that they can avoid being hijacked by viruses. So, the team wondered whether a different version of a protein, possibly an ancestral form, could keep an organism alive but prevent viral replication.

Thioredoxin was a good test subject: it is found in all modern organisms and is essential for both hosts and invading ...

Interested in reading more?

Become a Member of

The Scientist Logo
Receive full access to more than 35 years of archives, as well as TS Digest, digital editions of The Scientist, feature stories, and much more!
Already a member? Login Here

Related Topics

Meet the Author

  • Ashley started at The Scientist in 2018. Before joining the staff, she worked as a freelance editor and writer, a writer at the Simons Foundation, and a web producer at Science News, among other positions. She holds a bachelor’s degree in journalism from the University of Tennessee, Knoxville, and a master’s degree in science writing from MIT. Ashley edits the Scientist to Watch and Profile sections of the magazine and writes news, features, and other stories for both online and print.

    View Full Profile
Share
Illustration of a developing fetus surrounded by a clear fluid with a subtle yellow tinge, representing amniotic fluid.
January 2026

What Is the Amniotic Fluid Composed of?

The liquid world of fetal development provides a rich source of nutrition and protection tailored to meet the needs of the growing fetus.

View this Issue
Human-Relevant In Vitro Models Enable Predictive Drug Discovery

Advancing Drug Discovery with Complex Human In Vitro Models

Stemcell Technologies
Redefining Immunology Through Advanced Technologies

Redefining Immunology Through Advanced Technologies

Ensuring Regulatory Compliance in AAV Manufacturing with Analytical Ultracentrifugation

Ensuring Regulatory Compliance in AAV Manufacturing with Analytical Ultracentrifugation

Beckman Coulter Logo
Conceptual multicolored vector image of cancer research, depicting various biomedical approaches to cancer therapy

Maximizing Cancer Research Model Systems

bioxcell

Products

Sino Biological Logo

Sino Biological Pioneers Life Sciences Innovation with High-Quality Bioreagents on Inside Business Today with Bill and Guiliana Rancic

Sino Biological Logo

Sino Biological Expands Research Reagent Portfolio to Support Global Nipah Virus Vaccine and Diagnostic Development

Beckman Coulter

Beckman Coulter Life Sciences Partners with Automata to Accelerate AI-Ready Laboratory Automation

Refeyn logo

Refeyn named in the Sunday Times 100 Tech list of the UK’s fastest-growing technology companies